Double Blind, Double-Dummy, Randomised, Placebo Controlled Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects.

Trial Profile

Double Blind, Double-Dummy, Randomised, Placebo Controlled Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Lamotrigine; Vofopitant
  • Indications Bipolar disorders; Epilepsy; Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Apr 2011 Planned end date changed from 1 Oct 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 01 Apr 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Mar 2010 Planned end date changed from 1 Oct 2009 to 1 Oct 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top